SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002591
Filing Date
2015-11-12
Accepted
2015-11-12 06:09:45
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20150930x10q.htm 10-Q 1112693
2 EX-31.1 glyc-20150930ex31159ab27.htm EX-31.1 17762
3 EX-31.2 glyc-20150930ex3124c3d1a.htm EX-31.2 16855
4 EX-32.1 glyc-20150930ex321dd7e98.htm EX-32.1 10146
  Complete submission text file 0001558370-15-002591.txt   4165093

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20150930.xml EX-101.INS 884689
6 EX-101.SCH glyc-20150930.xsd EX-101.SCH 29342
7 EX-101.CAL glyc-20150930_cal.xml EX-101.CAL 35200
8 EX-101.DEF glyc-20150930_def.xml EX-101.DEF 96712
9 EX-101.LAB glyc-20150930_lab.xml EX-101.LAB 242503
10 EX-101.PRE glyc-20150930_pre.xml EX-101.PRE 189486
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 151221139
SIC: 2834 Pharmaceutical Preparations